Morgan Stanley »

Miragen Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.2M 321k 13.01
2024-03-31 $9.8M 563k 17.51
2023-12-31 $11M 525k 21.78
2023-09-30 $5.1M 334k 15.34
2023-06-30 $1.7M 70k 23.79
2022-12-31 $9.8M 335k 29.21
2022-06-30 $251k 28k 9.09
2022-03-31 $640k 35k 18.32
2021-06-30 $128k 7.0k 18.33